SHE:300942 Revenue

Shenzhen Bioeasy Biotechnology had revenue of 76.35M CNY in the quarter ending September 30, 2025, with 40.34% growth. This brings the company's revenue in the last twelve months to 251.83M, up 1.93% year-over-year. In the year 2024, Shenzhen Bioeasy Biotechnology had annual revenue of 224.25M, down -11.75%.

Revenue (ttm)

251.83M

Revenue Growth

+1.93%

P/S Ratio

15.14

Revenue / Employee

524.66K

Employees

480

Market Cap

3.81B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	224.25M	-29.86M	-11.75%
Dec 31, 2023	254.11M	-432.79M	-63.01%
Jan 1, 2023	686.90M	89.36M	14.95%
Jan 1, 2022	597.54M	339.08M	131.20%
Dec 31, 2020	258.46M	19.28M	8.06%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Shen Lian Biomedical	288.27M
Boji Medical Technology	770.19M
Qingdao Vland Biotech INC.	1.39B
Baolingbao Biology	2.69B
Zhejiang Wecome Pharmaceutical Company	131.67M
Yantai Zhenghai Biotechnology	347.60M
Beijing Kawin Technology Share-Holding	1.15B
Zhejiang Shouxiangu Pharmaceutical	642.66M

Revenue Rankings